Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment
- Status
- RECRUITING
- Phase
- N/A
A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers
- Status
- RECRUITING
- Phase
- PHASE1
Tucidinostat and Metronomic Capecitabine for Metastatic Triple-negative Breast Cancer:a Multicenter,Open-label, Randomized Controlled, Phase II Clinical Trial
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Predicting Olaparib Sensitivity in Patients With Unresectable Locally Advanced/Metastatic HER2-negative Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cardiac Outcomes With Near-Complete Estrogen Deprivation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Eribulin as a Second-line Treatment in Triple-negative Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) Signature
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate LYL797 in Adults With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Atezolizumab Plus CArboplatin Plus Nab-paclitaxel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
- Status
- WITHDRAWN
- Phase
- PHASE2
To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2